Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Feasibility Study: Histological Characterization After Treatment With the Ulthera® System

This study has been terminated.
(Slow subject enrollment; study to be obtained is no longer required.)
Sponsor:
Information provided by (Responsible Party):
Ulthera, Inc
ClinicalTrials.gov Identifier:
NCT01713569
First received: October 22, 2012
Last updated: November 1, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2013
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)